Matches in SemOpenAlex for { <https://semopenalex.org/work/W2574385171> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W2574385171 abstract "Abstract The leukemia-associated antigen PRAME (preferentially expressed antigen of melanoma) is frequently expressed in several solid tumors. Earlier, we reported (Greiner et al., Blood 2006) that co-expression of leukemia-associated antigens including PRAME constituted a favorable prognostic parameter for AML patients. By microassay analysis and conventional RT-PCR, we detected over-expression of PRAME in more than 60% of AML and of CML patients. In contrast, PRAME is expressed neither in normal CD34-positive hematopoietic stem cells nor in normal tissues (other than testis and placenta). Here, we describe for the first time that retinoic acid-induced cell proliferation and differentiation of several AML cell lines is dependent on PRAME expression: PRAME negative cell lines treated with all-trans retinoic acid (ATRA) in cell culture showed lower cell proliferation than PRAME positive cells as assessed by cell counts and FACS analysis for BrdU, but an increase of cell differentiation detected by FACS analysis for CD66b in contrast with PRAME positive leukemia cell lines. The leukemia-associated antigen PRAME seems to be responsible for the resistance of PRAME-positive AML to ATRA treatment. We detected no differences in induction of apoptosis in PRAME-positive or PRAME-negative cell lines treated with ATRA in FACS analysis for annexin. Over-expression of the antigen and this critical role of PRAME in cell differentiation might be the reason for specific T cell induction against PRAME-derived peptides. To detect specific T cell responses against PRAME-derived peptides we examined samples from healthy volunteers and AML patients. Positive results in ELISPOT assays for IFN-g and Granzyme B secretion were observed in 70% of AML cases analyzed for the peptide PRAME-P3. In chromium release assays, we found a PRAME-specific cell lysis of PRAME-positive AML blasts. Taken together, PRAME is involved in a crucial mechanism for cell growth of leukemic cells, induces specific T cell responses in a high frequency of AML patients, and this constitutes an appropriate target structure for specific immunotherapies or other targeted therapies in AML." @default.
- W2574385171 created "2017-01-26" @default.
- W2574385171 creator A5017514499 @default.
- W2574385171 creator A5020662983 @default.
- W2574385171 creator A5031568690 @default.
- W2574385171 creator A5040956966 @default.
- W2574385171 creator A5045920008 @default.
- W2574385171 creator A5065365364 @default.
- W2574385171 creator A5089395073 @default.
- W2574385171 creator A5090085247 @default.
- W2574385171 date "2008-11-16" @default.
- W2574385171 modified "2023-09-30" @default.
- W2574385171 title "The Leukemia-Associated Antigen PRAME Is Overexpressed in Myeloid Leukemias and Inhibits Cell Differentiation by Blocking the Receptor for Retinoic Acid (RAR)-Signaling in Vitro and Is Therefore a Interesting Candidate for Targeted Immunotherapies." @default.
- W2574385171 doi "https://doi.org/10.1182/blood.v112.11.1524.1524" @default.
- W2574385171 hasPublicationYear "2008" @default.
- W2574385171 type Work @default.
- W2574385171 sameAs 2574385171 @default.
- W2574385171 citedByCount "0" @default.
- W2574385171 crossrefType "journal-article" @default.
- W2574385171 hasAuthorship W2574385171A5017514499 @default.
- W2574385171 hasAuthorship W2574385171A5020662983 @default.
- W2574385171 hasAuthorship W2574385171A5031568690 @default.
- W2574385171 hasAuthorship W2574385171A5040956966 @default.
- W2574385171 hasAuthorship W2574385171A5045920008 @default.
- W2574385171 hasAuthorship W2574385171A5065365364 @default.
- W2574385171 hasAuthorship W2574385171A5089395073 @default.
- W2574385171 hasAuthorship W2574385171A5090085247 @default.
- W2574385171 hasConcept C109159458 @default.
- W2574385171 hasConcept C147483822 @default.
- W2574385171 hasConcept C203014093 @default.
- W2574385171 hasConcept C2778461978 @default.
- W2574385171 hasConcept C2778729363 @default.
- W2574385171 hasConcept C28328180 @default.
- W2574385171 hasConcept C502942594 @default.
- W2574385171 hasConcept C86803240 @default.
- W2574385171 hasConcept C95444343 @default.
- W2574385171 hasConceptScore W2574385171C109159458 @default.
- W2574385171 hasConceptScore W2574385171C147483822 @default.
- W2574385171 hasConceptScore W2574385171C203014093 @default.
- W2574385171 hasConceptScore W2574385171C2778461978 @default.
- W2574385171 hasConceptScore W2574385171C2778729363 @default.
- W2574385171 hasConceptScore W2574385171C28328180 @default.
- W2574385171 hasConceptScore W2574385171C502942594 @default.
- W2574385171 hasConceptScore W2574385171C86803240 @default.
- W2574385171 hasConceptScore W2574385171C95444343 @default.
- W2574385171 hasLocation W25743851711 @default.
- W2574385171 hasOpenAccess W2574385171 @default.
- W2574385171 hasPrimaryLocation W25743851711 @default.
- W2574385171 hasRelatedWork W1983074731 @default.
- W2574385171 hasRelatedWork W1986597996 @default.
- W2574385171 hasRelatedWork W2022061149 @default.
- W2574385171 hasRelatedWork W2042879110 @default.
- W2574385171 hasRelatedWork W2045932073 @default.
- W2574385171 hasRelatedWork W2051231514 @default.
- W2574385171 hasRelatedWork W2075709249 @default.
- W2574385171 hasRelatedWork W2090888112 @default.
- W2574385171 hasRelatedWork W2151883962 @default.
- W2574385171 hasRelatedWork W2266312779 @default.
- W2574385171 hasRelatedWork W2481167207 @default.
- W2574385171 hasRelatedWork W2516315956 @default.
- W2574385171 hasRelatedWork W2560676803 @default.
- W2574385171 hasRelatedWork W2583108916 @default.
- W2574385171 hasRelatedWork W2588789050 @default.
- W2574385171 hasRelatedWork W2588796192 @default.
- W2574385171 hasRelatedWork W2591676839 @default.
- W2574385171 hasRelatedWork W2592296717 @default.
- W2574385171 hasRelatedWork W2593351814 @default.
- W2574385171 hasRelatedWork W2565991894 @default.
- W2574385171 isParatext "false" @default.
- W2574385171 isRetracted "false" @default.
- W2574385171 magId "2574385171" @default.
- W2574385171 workType "article" @default.